Traders assign a 77% implied probability against the CDC issuing a Level 4 travel warning by year-end because current epidemiological surveillance shows no ongoing outbreaks or transmission patterns meeting the criteria for the highest alert level. Level 4 advisories apply to severe, widespread health risks involving limited treatment options and high potential for rapid spread. Official monitoring indicates stable case trends without novel pathogens or surges that would prompt escalation from lower advisory tiers. The market consensus reflects the lack of recent data shifts supporting such a designation, though evolving surveillance reports or unexpected clusters could introduce uncertainty before December 31.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertCDC gibt Warnung der Stufe 4 bis zum 31. Dezember aus?
Ja
$71,848 Vol.
$71,848 Vol.
Ja
$71,848 Vol.
$71,848 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Markt eröffnet: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Traders assign a 77% implied probability against the CDC issuing a Level 4 travel warning by year-end because current epidemiological surveillance shows no ongoing outbreaks or transmission patterns meeting the criteria for the highest alert level. Level 4 advisories apply to severe, widespread health risks involving limited treatment options and high potential for rapid spread. Official monitoring indicates stable case trends without novel pathogens or surges that would prompt escalation from lower advisory tiers. The market consensus reflects the lack of recent data shifts supporting such a designation, though evolving surveillance reports or unexpected clusters could introduce uncertainty before December 31.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen